MannKind Corp. has 979 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 13.4%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit mannkindcorp.com to learn more
As of September 2025
MannKind
workforce metrics
Headcount
979
Avg. Salary
$147.4k
Tenure
3.7yr
Growth Rate
13.4%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of MannKind annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of MannKind annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?